1) Seisen T, et al : Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma. J Clin Oncol 35 : 852-860, 2017
2) Necchi A, et al : Adjuvant Chemotherapy After Radical Nephroureterectomy Does Not Improve Survival in Patients with Upper Tract Urothelial Carcinoma : A Joint Study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration. BJU Int 121 : 252-259, 2018
3) Kikuchi E, et al : Lymphovascular Invasion Predicts Clinical Outcomes in Patients with Node-Negative Upper Tract Urothelial Carcinoma. J Clin Oncol 27 : 612-618, 2009
4) Matsunaga T, et al : Adjuvant Chemotherapy Improves Overall Survival in Patients with Localized Upper Tract Urothelial Carcinoma Harboring Pathologic Vascular Invasion : A Propensity Score-Matched Analysis of Multi-Institutional Cohort. World J Urol 38 : 3183-3190, 2020
5) Yafi FA, et al : Adjuvant Chemotherapy for Upper-Tract Urothelial Carcinoma Treated with Nephroureterectomy : Assessment of Adequate Renal Function and Influence on Outcome. Urol Oncol 32 : 31 e17-24, 2014
6) Leow JJ, et al : Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma : A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy. Eur Urol 79 : 635-654, 2021
7) Birtle A, et al : Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT trial) : A Phase 3, Open-Label, Randomised Controlled Trial. Lancet 395 : 1268-1277, 2020
8) Bajorin DF, et al : Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma. N Engl J Med 384 : 2102-2114, 2021
9) Bellmunt J, et al : Adjuvant Atezolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma (IMvigor010) : A Multicentre, Open-Label, Randomised, Phase 3 Trial. Lancet Oncol 22 : 525-537, 2021